Ezutromid
| CAS No. | 945531-77-1 | Cat. No. | BCP18328 |
| Name | Ezutromid | ||
| Synonyms | SMT C1100;SMT-C1100;SMTC1100;VOX C1100;VOXC1100;VOX-C1100;BMN 195;BMN195;BMN-195; | ||
| Formula | C19H15NO3S | M. Wt | 337.39 |
| Description | Ezutromid, also known as BMN-195 and SMTC-1100, is a first orally bioavailable utrophin's translation modulator. Duchenne muscular dystrophy (DMD) is a lethal, progressive muscle wasting disease caused by a loss of sarcolemmal bound dystrophin, which results in the death of the muscle fibers leading to the gradual depletion of skeletal muscle. | ||
| Pathways | Others Pathway | ||
| Targets | Others | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.